{"id":"NCT01391793","sponsor":"Nader Shaikh","briefTitle":"Corticosteroids for Children With Febrile Urinary Tract Infections","officialTitle":"Corticosteroids for Children With Febrile Urinary Tract Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2018-03-30","completion":"2018-03-30","firstPosted":"2011-07-12","resultsPosted":"2019-07-02","lastUpdate":"2019-07-02"},"enrollment":546,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Acute Urinary Tract Infection","Urinary Tract Infection"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":["Inactive medicine"]},{"type":"DRUG","name":"Dexamethasone","otherNames":["Prelone","Orapred","Corticosteroid"]}],"arms":[{"label":"Adjuvant dexamethasone","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"In this study the investigators will determine whether corticosteroids given at the time of urinary tract infection help prevent permanent damage to the kidneys.","primaryOutcome":{"measure":"The Distribution of Children With Renal Scarring at the Outcome Dimercaptosuccinic Acid (DMSA) Renal Scan","timeFrame":"The outcome DMSA scan was 5-24 months from enrollment. The mean number of months was 6.1.","effectByArm":[{"arm":"Adjuvant Dexamethasone","deltaMin":12,"sd":null},{"arm":"Placebo","deltaMin":22,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.16"}]},"eligibility":{"minAge":"2 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":13},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["34251495","32556960"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":271},"commonTop":["Fever","Fussiness","Diarrhea","Urinary Tract Infection (UTI) symptoms"]}}